Related Experiment Videos
[Benign tumours of the intestinal tract (author's transl)]
Zentralblatt Fur Chirurgie
|January 1, 1976
Abstract:
Benign tumours of the intestinal tract are rare. Frequently they tend to being malignant. Clinical symptoms are massive bleeding, stenosis, invagination, perforation. A reliable diagnosis is difficult.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Outcomes of self-trial without catheter pathway following elective urological surgery.
Annals of the Royal College of Surgeons of England·2026
Synthesis and crystal structure of 2,2,2-tri-chloroethyl N-{4-[6-(1-hy-droxy-eth-yl)-1,2,4,5-tetra-zin-3-yl]benz-yl}carbamate.
Acta crystallographica. Section E, Crystallographic communications·2025
Intranasal orexin A modulates sympathetic vascular tone: a pilot study in healthy male humans.
Journal of neurophysiology·2022
Stress-induced impairment of fear extinction recall is associated with changes in neuronal activity patterns in PVT.
Progress in neuro-psychopharmacology & biological psychiatry·2021
Prosthetics in antiquity-An early medieval wearer of a foot prosthesis (6th century AD) from Hemmaberg/Austria.
International journal of paleopathology·2018
[Thoracic Surgical Approaches - From Open Thoracotomy to Robot-Assisted Surgery].
Zentralblatt fur Chirurgie·2026
[Value of Clinical Video Registries for Research and Teaching in Minimally Invasive and Robotic Surgery].
Zentralblatt fur Chirurgie·2026
[Rescue Resections in Thoracic Surgery for Septic Lung Carcinomas Undergoing Systemic Therapy: a Case Series].
Zentralblatt fur Chirurgie·2026
[Digital Twins in Surgery].
Zentralblatt fur Chirurgie·2026
[Preventing Complications in Hepatopancreatobiliary Surgery].
Zentralblatt fur Chirurgie·2026
Follicular lymphoma and the microenvironment: potential targets and biomarkers.
Expert review of clinical immunology·2026
Targeting the HEC1-NEK2 Axis Suppresses DLBCL Progression and Overcomes Vincristine Resistance.
Molecular cancer therapeutics·2026
Bufalin Inhibits Melanoma Progression and Endothelial Angiogenic Phenotypes via AKT Signaling.
Cancer reports (Hoboken, N.J.)·2026